The CUD participants were recruited in this ancillary study from a wider sample of treatment-seeking patients participating in the Brainswitch project, a double-blind, sham-controlled trial testing the ability of repetitive transcranial magnetic stimulation to treat CUD (preliminary data published in Martinotti et al
Can alleviate symptoms of chronic conditions like fibromyalgia, fatigue, and migraines
Seek urgent same-day assessment for rapidly progressive neurological symptoms, and emergency care for severe breathlessness, chest pain, or fainting
Tesamorelin is FDA-approved under the brand name Egrifta (approved 2010) for treatment of excess abdominal fat (lipodystrophy) in HIV-positive adults receiving antiretroviral therapy
Die Realitt ist, dass alle verfgbaren Humandaten aus winzigen offenen Studien stammen und keine greren kontrollierten Trials existieren
12 min, each), the supernatants were membrane-filtered (0.2 m